ABSTRACT
Abstract: Background: Pityriasis rosea is a common papulosquamous disorder. However, its etiology and pathogenesis remain unclear. Objective: We investigate the types of inflammatory cells infiltrating the lesional skin of pityriasis rosea and demonstrate whether T-cell-mediated immunity is involved in the pathogenesis of this condition or not. Methods: The biopsies were taken from the lesional skin of 35 cases of patients diagnosed with pityriasis rosea. The specimens were prepared in paraffin sections, then submitted to routine immunohistochemistry procedures using monoclonal antibodies directed against CD3, CD4, CD8, CD20 and CD45RO and horseradish peroxidase-labeled goat anti-human antibodies. The positive sections were determined by the ratio and staining intensity of positive inflammatory cells. Results: The mean score of positive CD3, CD4, CD8, and CD45RO staining was respectively 3.74±3.88, 5.67±4.40, 2.94±3.42 and 7.68±4.33 in these pityriasis rosea patients (P<0.001). The percentage of positive staining was 54.29% (19/35), 69.7% (23/33), 40% (14/35) and 79.41% (27/34) (P<0.05). However, the staining of CD20 was negative in all samples. The mean score of CD3 staining in patients with time for remission ≤60 days (4.90±4.21) was higher than that in patients with time for remission >60 days (2.00±2.5) (P<0.05), whereas no statistical difference in the mean score of CD4, CD8 and CD45RO staining was observed. study liMitations: The sample size and the selected monoclonal antibody are limited, so the results reflect only part of the cellular immunity in the pathogenesis of pityriasis rosea. Conclusion: Our findings support a predominantly T-cell mediated immunity in the development of pityriasis rosea.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Young Adult , T-Lymphocyte Subsets/pathology , Pityriasis Rosea/pathology , Reference Values , Staining and Labeling , Time Factors , Biopsy , Immunohistochemistry , CD4-Positive T-Lymphocytes/pathology , T-Lymphocyte Subsets/immunology , Pityriasis Rosea/immunology , Leukocyte Common Antigens/analysis , CD3 Complex/analysis , CD8-Positive T-Lymphocytes/pathology , Immunity, CellularABSTRACT
RESUMEN A pesar de que la Pitiriasis Rosada se considera una condición cutánea benigna, en el marco del embarazo, hay estudios que relacionan la aparición de esta patología con complicaciones asociadas en el feto. Metodología: Se realiza un reporte de caso, prospectivo, a una mujer de 36 años chilena que presentó esta patología durante la semana 12 de gestación. El objetivo fue describir, la evolución y control y contrastar su evolución con la evidencia científica actual sobre esta temática. Resultados: Paciente presenta placas eritematodescamativas concordantes con diagnóstico de pitiriasis rosada (superficie afectada menos al 50% de su cuerpo), sin presentar enantema, ni síntomas sistémicos. Tuvo un recién nacido sano a las 38 semanas de gestación, sin presentar ningún efecto adverso de los que relaciona la literatura analizada. Conclusiones: Distintos estudios han estudiado los posibles efectos adversos en el feto en madres que han presentado Pitiriasis Rosada en el embarazo, sin embargo, en este reporte de caso no se presentaron complicaciones asociadas. Faltan estudios realizados en mayor cantidad de pacientes.
ABSTRACT Although Pityriasis Rosea is considered a benign cutaneous condition, in the context of pregnancy, there are studies that relate the appearance of this pathology with associated complications in the fetus. Methodology: A prospective case report was made to a 36-year-old Chilean woman who presented this pathology during the twelve weeks of pregnancy. The objective was to describe, the evolution and control and to contrast its evolution with the current scientific evidence on this subject. Results: Patient presents concordant erythematous-desquamative plaques with diagnosis of Pityriasis Rosea (surface affected less than 50% of his body), without presenting enanthem, nor systemic symptoms. Had a healthy newborn at 38 weeks of gestation, without presenting any adverse effect related to the analyzed literature. Conclusions: Different studies have studied the possible adverse effects on the fetus in mothers who have presented pityriasis rosea in pregnancy, however in this case report there were no associated complications. Missing studies in a greater number of patients.
Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Adult , Pityriasis Rosea/complications , Pityriasis Rosea/diagnosis , Pityriasis Rosea/prevention & control , Pregnancy Complications , Pityriasis Rosea/pathology , Pityriasis Rosea/virology , Herpesvirus 6, Human/isolation & purification , Herpesvirus 7, Human/isolation & purificationABSTRACT
La pitiriasis rosada es una enfermedad eritematoescamosa autolimitada que afecta exclusivamente la piel con probable etiología viral. Se realizó un trabajo descriptivo observacional prospectivo donde se incluyeron 119 pacientes que consultaron en nuestro servicio en un periodo de 2 años. El objetivo fue analizar las diferentes formas clínicas y variables que intervienen en dicha patología. En los resultados destacamos que el hallazgo de formas clínicas típicas fue 75,4% y atípicas en un 24,6%. El Estrés psicofísico actuó como desencadenante en un 39,5% de los casos, mientras que en el hemograma se observó la presencia de monocitosis en un 82,1% de los pacientes y eosinofilia en un 22,1%. Resultaría de interés, en investigaciones futuras, la evaluación del estrés psicofísico como factor desencadenante del cuadro dermatológico, considerando que no ha sido desarrollado apropiadamente en la bibliografía consultada.
Subject(s)
Humans , Pityriasis Rosea/epidemiology , Pityriasis Rosea/pathology , Skin/pathology , Risk FactorsABSTRACT
Apresentamos uma atualizaçäo sobre as dermatoses que ocorrem no pavilhäo auricular. Propomos uma classificaçäo em sete grupos e realizamos uma sucinta descriçäo clínica de cada uma das 84 entidades catalogadas, de forma didática, com a finalidade de auxiliar o médico, sobretudo o clínico geral, o dermatologista e o otorrinolaringologista, no diagnóstico de tais patologias.